Literature DB >> 15743835

The exon 8-containing prosaposin gene splice variant is dispensable for mouse development, lysosomal function, and secretion.

Tsadok Cohen1, Wojtek Auerbach, Liat Ravid, Jacques Bodennec, Amos Fein, Anthony H Futerman, Alexandra L Joyner, Mia Horowitz.   

Abstract

Prosaposin is a multifunctional protein with diverse functions. Intracellularly, prosaposin is a precursor of four sphingolipid activator proteins, saposins A to D, which are required for hydrolysis of sphingolipids by several lysosomal exohydrolases. Secreted prosaposin has been implicated as a neurotrophic, myelinotrophic, and myotrophic factor as well as a spermatogenic factor. It has also been implicated in fertilization. The human and the mouse prosaposin gene has a 9-bp exon (exon 8) that is alternatively spliced, resulting in an isoform with three extra amino acids, Gln-Asp-Gln, within the saposin B domain. Alternative splicing in the prosaposin gene is conserved from fish to humans, tissue specific, and regulated in the brain during development and nerve regeneration-degeneration processes. To elucidate the physiological role of alternative splicing, we have generated a mouse lacking exon 8 by homologous recombination. The exon 8 prosaposin mutant mice are healthy and fertile with no obvious phenotype. No changes were detected in prosaposin secretion or in accumulation and metabolism of gangliosides, sulfatides, neutral glycosphingolipids, neutral phospholipids, other neutral lipids, and ceramide. These data strongly indicate that the prosaposin variant containing the exon 8-encoded three amino acids is dispensable for normal mouse development and fertility as well as for prosaposin secretion and its lysosomal function, at least in the presence of the prosaposin variant missing the exon 8-encoded three amino acids.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15743835      PMCID: PMC1061615          DOI: 10.1128/MCB.25.6.2431-2440.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  66 in total

1.  A novel mutation in the coding region of the prosaposin gene leads to a complete deficiency of prosaposin and saposins, and is associated with a complex sphingolipidosis dominated by lactosylceramide accumulation.

Authors:  H Hulková; M Cervenková; J Ledvinová; M Tochácková; M Hrebícek; H Poupetová; A Befekadu; L Berná; B C Paton; K Harzer; A Böör; F Smíd; M Elleder
Journal:  Hum Mol Genet       Date:  2001-04-15       Impact factor: 6.150

2.  THE USE OF SEPHADEX FOR THE REMOVAL OF NONLIPID CONTAMINANTS FROM LIPID EXTRACTS.

Authors:  M A WELLS; J C DITTMER
Journal:  Biochemistry       Date:  1963 Nov-Dec       Impact factor: 3.162

3.  A simple method for the isolation and purification of total lipides from animal tissues.

Authors:  J FOLCH; M LEES; G H SLOANE STANLEY
Journal:  J Biol Chem       Date:  1957-05       Impact factor: 5.157

4.  Targeted disruption of the mouse prosaposin gene affects the development of the prostate gland and other male reproductive organs.

Authors:  C R Morales; Q Zhao; M El-Alfy; K Suzuki
Journal:  J Androl       Date:  2000 Nov-Dec

5.  Prosaposin: a myelinotrophic protein that promotes expression of myelin constituents and is secreted after nerve injury.

Authors:  M Hiraiwa; W M Campana; A P Mizisin; L Mohiuddin; J S O'Brien
Journal:  Glia       Date:  1999-06       Impact factor: 7.452

6.  A mutation in the saposin A domain of the sphingolipid activator protein (prosaposin) gene results in a late-onset, chronic form of globoid cell leukodystrophy in the mouse.

Authors:  J Matsuda; M T Vanier; Y Saito; J Tohyama; K Suzuki; K Suzuki
Journal:  Hum Mol Genet       Date:  2001-05-15       Impact factor: 6.150

7.  A procedure for fractionation of sphingolipid classes by solid-phase extraction on aminopropyl cartridges.

Authors:  J Bodennec; O Koul; I Aguado; G Brichon; G Zwingelstein; J Portoukalian
Journal:  J Lipid Res       Date:  2000-09       Impact factor: 5.922

8.  Prosaposin is immunolocalized to muscle and prosaptides promote myoblast fusion and attenuate loss of muscle mass after nerve injury.

Authors:  M Rende; E Brizi; R Donato; C Provenzano; R Bruno; A P Mizisin; R S Garrett; N A Calcutt; W M Campana; J S O'Brien
Journal:  Muscle Nerve       Date:  2001-06       Impact factor: 3.217

9.  Administration of prosaposin ameliorates spatial learning disturbance and reduces cavity formation following stab wounds in rat brain.

Authors:  I Hozumi; M Hiraiwa; T Inuzuka; Y Yoneoka; K Akiyama; R Tanaka; K Kikugawa; R Nakano; S Tsuji; J S O'Brien
Journal:  Neurosci Lett       Date:  1999-05-21       Impact factor: 3.046

10.  A fragment of prosaposin (SGP-1) from rooster sperm promotes sperm-egg binding and improves fertility in chickens.

Authors:  R H Hammerstedt; P G Cramer; G F Barbato; R P Amann; J S O'Brien; M D Griswold
Journal:  J Androl       Date:  2001 May-Jun
View more
  4 in total

1.  Assessing the fraction of short-distance tandem splice sites under purifying selection.

Authors:  Michael Hiller; Karol Szafranski; Rileen Sinha; Klaus Huse; Swetlana Nikolajewa; Philip Rosenstiel; Stefan Schreiber; Rolf Backofen; Matthias Platzer
Journal:  RNA       Date:  2008-02-11       Impact factor: 4.942

2.  GRAF1a is a brain-specific protein that promotes lipid droplet clustering and growth, and is enriched at lipid droplet junctions.

Authors:  Safa Lucken-Ardjomande Häsler; Yvonne Vallis; Helen E Jolin; Andrew N McKenzie; Harvey T McMahon
Journal:  J Cell Sci       Date:  2014-09-04       Impact factor: 5.285

3.  Cardiogel: a nano-matrix scaffold with potential application in cardiac regeneration using mesenchymal stem cells.

Authors:  Rajalakshmi Santhakumar; Prasanna Vidyasekar; Rama Shanker Verma
Journal:  PLoS One       Date:  2014-12-18       Impact factor: 3.240

4.  Decrease in prosaposin in the Dystrophic mdx mouse brain.

Authors:  Hui-Ling Gao; Cheng Li; Hiroaki Nabeka; Tetsuya Shimokawa; Naoto Kobayashi; Shouichiro Saito; Zhan-You Wang; Ya-Ming Cao; Seiji Matsuda
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.